Home NAION

NAION

2 Articles
FDA Warns of Rare Vision Loss Risk Linked to Ozempic, Wegovy and Other GLP-1 Drugs
Breaking NewsHealth NewsLatest News

FDA Warns of Rare Vision Loss Risk Linked to Ozempic, Wegovy and Other GLP-1 Drugs

The US Food and Drug Administration (FDA) has issued a new safety warning about a potential increased risk of a rare but serious...

liver disease
Latest News

Ozempic Side Effects: Weight Loss Drugs Linked to Rare But Serious Eye Problems, Study Warns

New Delhi, 13 August 2025: Weight loss medications like Ozempic, Wegovy, and other GLP-1 receptor agonists have gained massive popularity for their effectiveness...